Rilmenidine treatment in patients with mild to moderate arterial hypertension and metabolic syndrome

Rilmenidine treatment in patients with mild to moderate arterial hypertension and metabolic syndrome

Efficacy, tolerability and cardioprotective properties of rilmenidine were examined in patients with mild to moderate arterial hypertension (AH). The trial involved 51 hypertensive subjects, mean age 57,7+2,5 years. After wash-out period, rilmenidine was administered in the daily dose of 1-2 mg. At...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	S. S. Yakushin, N. I. Ivankova, N. S. Sazonova, N. V. Vilesova, G. O. Ivanova
Formáid:	Alt
Teanga:	Russian
Foilsithe / Cruthaithe:	«FIRMA «SILICEA» LLC 2004-12-01
Sraith:	Российский кардиологический журнал
Ábhair:	arterial hypertension metabolic syndrome cardioprotective effects rilmenidine
Rochtain ar líne:	https://russjcardiol.elpub.ru/jour/article/view/2326

Míreanna comhchosúla

EFFECT OF ANTIHYPERTENSIVE THERAPY WITH RILMENIDINE ON COGNITIVE FUNCTION IN ELDERLY HYPERTENSIVE PATIENTS
de réir: S. V. Nedogoda, et al.
Foilsithe / Cruthaithe: (2016-01-01)

ASSESSMENT OF RILMENIDINE EFFICIENCY IN PATIENTS WITH ARTERIAL HYPERTENSION WITH DETERIORATION OF DAILY PROFILE OF BLOOD PRESSURE
de réir: P. P. Tikhonov, et al.
Foilsithe / Cruthaithe: (2015-12-01)

Perspectives of decreasing individual cardiovascular risk in high- and very high risk patients with arterial hypertension, treated with rilmenidine
de réir: S. V. Nedogoda, et al.
Foilsithe / Cruthaithe: (2005-06-01)

Workplace arterial hypertension: potential of rilmenidine-based combination therapy
de réir: S. I. Drozdetsky, et al.
Foilsithe / Cruthaithe: (1970-01-01)

Rilmenidine treatment in hypertensive patients with cerebrovascular transient ischemic attacks
de réir: A. P. Kondrakhin, et al.
Foilsithe / Cruthaithe: (2005-10-01)

Rilmenidine therapy potential in pharmaceutical correction of endothelial dysfunction among women with arterial hypertension, Type 2 diabetes mellitus, and visceral obesity
de réir: E. V. Eliseeva, et al.
Foilsithe / Cruthaithe: (1970-01-01)

THE WAYS OF SYMPATHETIC SYSTEM OVERACTIVITY BLOCKING: RILMENIDINE VERSUS ATENOLOL
de réir: Y. R. Kasherininov, et al.
Foilsithe / Cruthaithe: (2016-01-01)

Autophagy and anti-inflammation ameliorate diabetic neuropathy with Rilmenidine
de réir: Mehmet Burak Yalçın, et al.
Foilsithe / Cruthaithe: (2023-12-01)

Rilmenidine Protects Against Joint Damage in MIA-induced Model of Osteoarthritis in Rats
de réir: Osman Kukula, et al.
Foilsithe / Cruthaithe: (2024-02-01)

Main results of the Russian trial «ALTAIR»
de réir: E. V. Shlyakhto, et al.
Foilsithe / Cruthaithe: (2006-02-01)

Comparison in conscious rabbits of the baroreceptor-heart rate reflex effects of chronic treatment with rilmenidine, moxonidine, and clonidine
de réir: Monique L Parkin, et al.
Foilsithe / Cruthaithe: (2016-11-01)

ARTERIAL HYPERTENSION IN YOUNG PEOPLE: EFFICACY OF SYMPATHOLYTIC THERAPY
de réir: N. N. Nikitina, et al.
Foilsithe / Cruthaithe: (2015-12-01)

Effects of centrally acting antihypertensive drugs on the microcirculation of spontaneously hypertensive rats
de réir: V. Estato, et al.
Foilsithe / Cruthaithe: (2004-10-01)

PHARMACEUTICAL CORRECTION OF VASCULAR DISTURBANCES IN PATIENTS WITH ARTERIAL HYPERTENSION
de réir: L. A. Khaisheva, et al.
Foilsithe / Cruthaithe: (2010-10-01)

Combined treatment of arterial hypertension: focus on calcium antagonist and ACE inhibitor combination
de réir: V. I. Makolkin
Foilsithe / Cruthaithe: (2008-12-01)

Not first‐line antihypertensive agents, but still effective—The efficacy and safety of imidazoline receptor agonists: A network meta‐analysis
de réir: András Érszegi, et al.
Foilsithe / Cruthaithe: (2024-06-01)

Cerebral blood flow and blood rheology in hypertensive patients during rilmenidine treatment
de réir: L. I. Markova, et al.
Foilsithe / Cruthaithe: (2004-06-01)

BISOPROLOL AND METFORMIN IN PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC SYNDROME
de réir: V. A. Nevzorova, et al.
Foilsithe / Cruthaithe: (2015-12-01)

Prevalence of metabolic syndrome and its components in patients with arterial hypertension and obesity
de réir: I. E. Chazova, et al.
Foilsithe / Cruthaithe: (2005-12-01)

Valsartan effects on platelet activity in patients with arterial hypertension and metabolic syndrom
de réir: I. N. Medvedev, et al.
Foilsithe / Cruthaithe: (2007-06-01)

Reduced platelet aggregation in losartan-treated patients with arterial hypertension and metabolic syndrome
de réir: I. N. Medvedev, et al.
Foilsithe / Cruthaithe: (2008-10-01)

Eprosartan effects on intravascular platelet activity in patients with arterial hypertension and metabolic syndrome
de réir: I. N. Medvedev, et al.
Foilsithe / Cruthaithe: (2008-02-01)

Intravascular platelet activity correction by fosinopril in arterial hypertension patients with metabolic syndrome
de réir: I. N. Medvedev, et al.
Foilsithe / Cruthaithe: (2006-10-01)

Microcirculatory function in patients with arterial hypertension, metabolic syndrome and diabetes mellitus
de réir: A. P. Vasilyev, et al.
Foilsithe / Cruthaithe: (2008-10-01)

Some hormonal systems in males with arterial hypertension and metabolic syndrome
de réir: A. N. Britov, et al.
Foilsithe / Cruthaithe: (2006-06-01)

CORRECTION OF AGGREGATIVE FUNCTION OF THE TROMBOCYTES IN ARTERIAL HYPERTENSION PATIENTS WITH METABOLIC SYNDROM UNDER THE INFLUENCE OF SIMVASTATINE
de réir: N. J. Gromnazky, et al.
Foilsithe / Cruthaithe: (2003-12-01)

Metabolic syndrome in patients with arterial hypertension living in the Far North (on the example of the Khanty-Mansi Autonomous Okrug — Yugra)
de réir: E. G. Ivanova, et al.
Foilsithe / Cruthaithe: (2023-04-01)

The comorbid patients with arterial hypertension, chronic heart failure and chronic kidney disease: the role of fosinoprile
de réir: G. N. Gorokhovskaya, et al.
Foilsithe / Cruthaithe: (2018-04-01)

Arterial hypertension and metabolic syndrome: specifics of antihypertensive therapy
de réir: L. I. Abasova, et al.
Foilsithe / Cruthaithe: (2011-08-01)

Features of the clinical course of arterial hypertension in alien residents of Western Siberia with the establishment of patterns of metabolic changes
de réir: E. G. Ivanova, et al.
Foilsithe / Cruthaithe: (2022-07-01)

Spirapril effects on heart remodeling in patients with mild to moderate arterial hypertension
de réir: M. M. Beraya, et al.
Foilsithe / Cruthaithe: (2007-02-01)

Pathogenesis of arterial hypertension within the metabolic syndrome
de réir: A S Ryazanov, et al.
Foilsithe / Cruthaithe: (2003-03-01)

Antihypertensive spirapril effectiveness in patients with mild to moderate arterial hypertension
de réir: M. M. Beraya, et al.
Foilsithe / Cruthaithe: (1970-01-01)

Imidazoline receptor agonist moxonidine and arterial hypertension treatment in women with menopausal metabolic syndrome
de réir: E. V. Tishina, et al.
Foilsithe / Cruthaithe: (2011-06-01)

Moxonidine for arterial hypertension treatment in menopausal women with metabolic syndrome
de réir: V. V. Trusov, et al.
Foilsithe / Cruthaithe: (2007-08-01)

AFFECTIVE DISORDERS IN MEN WITH ARTERIAL HYPERTENSION IN COMBINATION WITH METABOLIC SYNDROME
de réir: Roman A. Yaskevich, et al.
Foilsithe / Cruthaithe: (2022-08-01)

AFFECTIVE DISORDERS IN WOMEN WITH ARTERIAL HYPERTENSION IN COMBINATION WITH METABOLIC SYNDROME
de réir: Roman A. Yaskevich, et al.
Foilsithe / Cruthaithe: (2022-06-01)

The efficacy of available supplements and medical drugs in longevity medicine - a review
de réir: Michał Łata, et al.
Foilsithe / Cruthaithe: (2025-01-01)

SHIFTWORK AS ONE OF RISK FACTORS OF ARTERIAL HYPERTENSION AND METABOLIC DISORDERS
de réir: I. S. Dzherieva, et al.
Foilsithe / Cruthaithe: (2015-12-01)

Advantages of telmisartan pharmacotherapy in elderly patients with arterial hypertension and metabolic syndrome who have suffered an ischemic stroke
de réir: O. A. Osipova, et al.
Foilsithe / Cruthaithe: (2022-10-01)